ITGB2 and inflammatory bowel disease: These changes were significant in inflammatory bowel disease (IBD) because blocking the terminal Lex motif reduces dysregulated transepithelial migration of neutrophils, presumably by inhibiting the binding of MAC-1 to ICAM-1 molecules expressed on the surface of the inflamed epithelium (66, 67).